| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Will Lawyers Sue Ford Motor Company on behalf of Shareholders if They Go Private? |
|
Digg It - Will Lawyers Sue Ford Motor Company on behalf of Shareholders if They Go Private?
We may see some interesting type lawsuits and new case law develop in t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product he very near future as Ford Motor Company’s stock drops. Why you ask? W ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ll it appears Ford Motor Company is going to go private, but in doing s lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. some might say that it is purposefully finding things to do in order t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe lower its stock price prior to going private. Will those shareholders d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro who have lost money due to the fast stock price drop sue? Will some law ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc er try to file that class-action case against Ford Motor Company? This easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi will be an interesting class-action lawsuit in that they are damned if nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically hey do and damned if they don’t and this could prevent future companies and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ from attempting to go private. More and more companies are considering ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi this due to the massive over regulation of the SEC Securities Exchange ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ommission and the incredible class-action lawsuits from groups of minor dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ty investors. Would such a suit hold water? No, probably not really be cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin cause all the US Automakers are having troubles. Even DaimlerChrysler i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen attempting to hold their head up high as they manuerver thru though ti t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel es and turbulent waters. General Motors, DaimlerChrysler and Ford Motor ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust Company have all announced lay-offs. Ford Motor Company announced 300,0 y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products 00 lay offs to occur over the next few years and 14,000 will be leaving . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de immediately whether they take the buy-put severance pay package or not. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip So, there are certainly some issues here as this game strategy un-folds tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Six Figure Success: How Coaches Can Build the Ideal Business and Profits
|